Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


instrAction and Protagen form strategic alliance


Dortmund, Germany, March 15, 2011 - instrAction GmbH, Ludwigshafen, the specialist for design and production of selective separation matrices and Protagen AG , Dortmund, a GMP certified service laboratory for protein analysis signed a strategic alliance for the development of customized instrAction ® Phases for downstream processing of biotherapeutics.

“The instrAction® Phases are proprietary synthetic chromatography phases which show excellent performance compared to commonly used matrices for e.g. antibody purification. The unique know-how and expertise of Protagen in GMP-compliant protein analysis and related services will be decisive for the development of a portfolio of new tailor made separation phases for the production of recombinant protein drugs, other biotherapeutics and biosimilars”, comments Dr. Thomas Schwarz, CEO of instrAction.

“In order to exploit the full value of this exciting new protein purification technology and to convince customers from pharma process development and production, it is important to provide convincing data sets from feasibility studies. Protagen has all the tools and know-how to support instrAction on its way to become the leading company in protein separation technology”, underscores Dr. Stefan Müllner, CEO of Protagen.


About Protagen AG - http://www.protagen.de/
Protagen AG is an international leading specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis. The innovations of Protagen are UNIarray®, a technology platform for the development of novel serum based diagnostics, as well as UNIchip®, a versatile product family of protein microarrays for faster development of antibodies.

About instrAction GmbH - www.instraction.com
instrAction, founded in 1997 and located at the BASF site in Ludwigshafen, develops and manufactures 'instrAction® phases” as novel highly selective resins for chromatography. The proprietary technology enables the immobilization of a wide variety of functional ligands on a polymer network, coated on very different porous backbone materials. Small molecules as well as substances with high molecular weight are separated by highly selective reversible interactions. The high selectivity of an instrAction stationary phase is thereby reached by multivalent-multimodal interactions between target molecule and the functional ligands of the phase, similar to the lock-and-key principle.


Contact
Dr. Stefan Müllner
CEO
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: info@protagen.de

Media Enquiries
Bettina Franz
Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Tel: +49 (0) 231 9742 6300
Fax: +49 (0) 231 9742 6301
E-Mail: bettina.franz@protagen.de


Publisher Contact Information:

Protagen
+49 (0) 231 9742 6300
bettina.franz@protagen.de

Company profile of Instraction GmbH
Past press releases of Instraction GmbH.

Data


22,390
Tech investments
From our Online Data Service
14,442
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Feb 21€11.0MConsumer electronics
Feb 20€3.4MBiopharmaceuticals
Feb 18€5.5MInternet services
Feb 18€0.5MBusiness applications
Feb 17N/AInternet commerce
Feb 15€6.0MInternet commerce
Feb 15€7.7MInternet commerce

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...

Dec 13
Versasec
new security survey shows it security spending will rise sharply in...

Nov 16
Versasec
versasec, digicert establish formal working relationship

Oct 18
Versasec
versasec launches vsec:cms s-series version 4.6

Oct 4
Versasec
versasec and zigg announce partnership





About usContact usLegal Information
Copyright © 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.